The Central Research Laboratory is always up for challenges in matters related to animal life science. In compliance with GLP, a modern R&D structure is used to carry out expansion in unexplored multi-principle fields such as drug discovery, medical technology, and biotechnology.
The ALS(Animal Life Science)building and Bioprocess Plant are among the few most advanced research facilities with state-of-the-art equipment in the country, where development of new medicinal products through application of gene recombinant technology is carried out. In particular, Bioprocess Plant is where research is focused on the development of next-generation core technology for the manufacturing of new drugs.
In addition, ZENOAQ has also put in more effort in the research and development of live poultry vaccines and made Nippon Biologicals, Inc. a part of ZENOAQ’s corporate group in order to further strengthen ZENOAQ’s foothold in the poultry field.